Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Deal abstention ahead if Valeant's $2.6bn bid for Medicis proceeds

This article was originally published in Scrip

Executive Summary

Acquisitive Valeant Pharmaceuticals International will have to put its big ticket purchases on hold for 12 months if it succeeds in pulling off its planned $2.6 billion acquisition of US dermatology and aesthetics firm Medicis.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC018644

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel